Mice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by Risperidone
Casandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie, Richard R. Neubig
This study develops a mouse model of GNAO1 R209H mutation, showing hyperlocomotion that is alleviated by risperidone.
Journal of Pharmacology and Experimental Therapeutics · Jan 6, 2020Peer-reviewedNeuroscience